Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

glaxosmithkline slovakia s.r.o. - paroxetín - 30 - antidepressiva

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

b.braun melsungen ag, nemecko - granisetrón - 20 - antiemetica, antivertiginosa

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teva b.v., holandsko - granisetrón - 20 - antiemetica, antivertiginosa

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

teva b.v., holandsko - granisetrón - 20 - antiemetica, antivertiginosa

Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

krka, d.d., novo mesto, slovinsko - multienzýmy (lipáza, proteáza a ďalšie) - 49 - digestiva, adsorbentia, acida

Európska únia - slovenčina - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - tropická horúčka - vakcíny - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 a 4. použitie dengvaxia by mali byť v súlade s oficiálne odporúčania.

Európska únia - slovenčina - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromyalgia

Európska únia - slovenčina - EMA (European Medicines Agency)

pierre fabre medicament - milnacipran - fibromyalgia

Európska únia - slovenčina - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidón palmitát - schizofrénie - psycholeptika - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Európska únia - slovenčina - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - antineoplastické činidlá - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.